Vripride PM 1mg/500mg/15mg Tablet SR
Marketer
Gopal Lifesciences
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Vripride PM 1mg/500mg/15mg Tablet SR
GlucoBalance PM, a triple-action tablet (1mg/500mg/15mg extended-release), effectively manages blood glucose. Combined with diet and exercise, it improves glycemic control in adult type 2 diabetics by enhancing insulin utilization. Dosage and duration should strictly follow your physician's instructions; take with food to prevent digestive discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; never double the dose. Overdosage risks dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to use, disclose kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before commencing treatment. Kidney function will be assessed before prescription. Limit alcohol consumption due to potential side effect exacerbation.
Uses of Vripride PM 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Vripride PM 1mg/500mg/15mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Vripride PM 1mg/500mg/15mg Extended-Release Tablet with food.
Common Side effects of Vripride PM 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Vripride PM 1mg/500mg/15mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Consume Vripride PM 1mg/500mg/15mg Extended-Release Tablet with food.
How Vripride PM 1mg/500mg/15mg Tablet SR works:
Vripride PM 1mg/500mg/15mg extended-release tablets contain glimepiride, metformin, and pioglitazone, three distinct antidiabetic agents. This triple combination improves blood glucose management when single or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Vripride PM 1mg/500mg/15mg SR tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Vripride PM 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Vripride PM 1mg/500mg/15mg SR tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use the extended-release Vripride PM 1mg/500mg/15mg tablet cautiously, potentially requiring dosage modification. Consult a physician for guidance. The medication is contraindicated in individuals with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Vripride PM 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. Vripride PM 1mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Vripride PM 1mg/500mg/15mg Tablet SR :
Should you forget a dose of Vripride PM 1mg/500mg/15mg Tablet SR, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vripride PM 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently